1 link tagged with all of: drug discovery + ai + pharmaceutical + healthcare + investment
Links
Nvidia Corp. will invest $1 billion over five years to establish a new artificial intelligence laboratory in collaboration with Eli Lilly & Co. The facility, located in Silicon Valley, aims to accelerate the application of AI in the pharmaceutical industry by leveraging Lilly's lab expertise.
- Nvidia will invest $1 billion over five years to build an AI drug discovery lab with Eli Lilly, located in Silicon Valley
- The lab will use Lilly's lab expertise combined with Nvidia's computational tools to predict how compounds interact with biological systems
- The goal is to speed up and cut costs in drug discovery while improving precision in targeting specific diseases
- The deal signals Nvidia's strategic push into healthcare as a growth area beyond its core computing and gaming business
drug discovery
pharmaceutical
healthcare
ai
investment